Andrew J. Schwab, Director at Camp4 Therapeutics Corp (CAMP), sold 191,865 shares at $4.76 ($880K) on 2026-08-19, disclosed to the SEC on 2026-08-21.
Open-market sale of $880k CAMP by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.76 | 45,147 | $215K | 24.4% |
| 2 | $4.54 | 114,700 | $521K | 59.2% |
| 3 | $4.50 | 32,018 | $144K | 16.4% |
| Total | $4.59 avg | 191,865 | $880K | 100% |
| Filing → |
| CAMP | SELL | 2026-08-31 | $1.6M | — | Filing → |
| CAMP | SELL | 2026-08-26 | $45 | — | Filing → |
| SKYE | SELL | 2026-08-20 | $140K | — | Filing → |